Thiru Balasubramaniam

European Parliament’s Committee on International Trade (INTA) adopts resolution on Multilateral negotiations in view of the 12th WTO Ministerial Conference in Geneva, 30 November to 3 December 2021

On Tuesday, 9 November 2021 the European Parliament’s Committee on International Trade (INTA) convened an extraordinary meeting from 9:00 to 12:00. INTA adopted resolution on Multilateral negotiations in view of the 12th WTO Ministerial Conference in Geneva, 30 November to 3 December 2021. The co-rapporteurs for this resolution include Bernd Lange (S&D) and Sven Simon …

European Parliament’s Committee on International Trade (INTA) adopts resolution on Multilateral negotiations in view of the 12th WTO Ministerial Conference in Geneva, 30 November to 3 December 2021 Read More »

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) roadmap

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) road map 24 February 2021 Whilst calls for better coordination in the EU pandemic response are welcome, HERA must put the global right to health, rather than regional biosecurity concerns, at its heart. Rapid operationalisation, as demanded by global public health needs, …

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) roadmap Read More »

The European Commission action plan on intellectual property – Of COVID-19, TRIPS, EU BARDA, march-in rights, patent pools, and compulsory licensing

Update: On Wednesday, 25 November 2020, the European Commission published its IP action plan:  Making the most of the EU’s innovative potential – An intellectual property action plan to support the EU’s recovery and resilience. KEI Europe’s President, Dr. Ellen ‘t Hoen provided the following reaction to the European Union’s action plan on intellectual property. …

The European Commission action plan on intellectual property – Of COVID-19, TRIPS, EU BARDA, march-in rights, patent pools, and compulsory licensing Read More »

KEI Europe comments on the European Commission’s roadmap for an Intellectual Property Action Plan

14 August 2020 Compulsory licensing in the Unitary Patent System.  There should be a provision for a unitary compulsory license in the unitary patent system, that is without prejudice to national compulsory licenses on the unitary patent right.   Non patent market exclusivities.  Sui generis exclusive rights regimes, such as but not limited to regulatory test …

KEI Europe comments on the European Commission’s roadmap for an Intellectual Property Action Plan Read More »

2020: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies

On 31 March 2020, the Office of the United States Trade Representative (USTR) published its 2020 National Trade Estimates Report on Foreign Trade Barriers (NTE). As USTR notes, in “accordance with section 181 of the Trade Act of 1974, as amended by section 303 of the Trade and Tariff Act of 1984 and amended by …

2020: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies Read More »

KEI Europe comments on the EU’s cancer roadmap

KEI Europe response to the European Union’s cancer roadmap 3 March 2020 Cell and gene therapies are among the more promising innovations to treat cancer. Chimeric Antigen Receptor T-Cell (“CAR T” or “CAR T-cell”) treatments involve a combination of  procedures that take place both in and outside of the body. Blood is taken from a …

KEI Europe comments on the EU’s cancer roadmap Read More »

January 2020: European Commission publishes its Report on the protection and enforcement of intellectual property rights in third countries

On 8 January 2020 the European Commission published a “Report on the protection and enforcement of intellectual property rights in third countries.” The objective of this report is to “identify third countries in which the state of IPR protection and enforcement (both online and offline) gives rise to the greatest level of concern” (European Commission, …

January 2020: European Commission publishes its Report on the protection and enforcement of intellectual property rights in third countries Read More »

Letter to Italian Minister of Health in support of Dr Luca Li Bassi

On Thursday, 7 November 2019, 21 civil society organizations and 24 individuals including public health experts, and legal analysts sent a letter to Italy’s new Minister of Health, Roberto Speranza expressing support for Dr Luca Li Bassi, the current Director General of Agenzia Italiana del Farmaco (AIFA). The pdf version of the letter can be …

Letter to Italian Minister of Health in support of Dr Luca Li Bassi Read More »